drugset / Trial / NCT03611426

Topical rhThrombin as an Adjunct to Hemostasis During Segmental Hepatectomy

NCT03611426

Phase 1/2 Completed 84 enrolled Suzhou Zelgen Biopharmaceuticals Co.,Ltd
RandomizedSequentialSingle-blindTreatment

Summary

rhThrombin is a serine protease from human.The study is to assess the Safety, Tolerability, Immunogenicity and efficacy of rhThrombin.

Timeline

Start
2017-11-29
Primary completion
2018-12-05
Completion
2019-07-30

Drugs

EvaluationDrugModalityDoseRoute
Subject rhThrombin Protein / enzyme biologic 500 unknown Topical
Subject rhThrombin Protein / enzyme biologic 1000 unknown Topical
Subject rhThrombin Protein / enzyme biologic 2000 unknown Topical

Indications

No indication recorded.